CA9 and carcinoma: To explore the clinical value of CAIX in patients with malignant tumors, we analyzed CAIX mRNA expression in data sets from The Cancer Genome Atlas (TCGA) and found that most CAIX transcripts were overexpressed in carcinoma tissues compared with noncancerous tissues (Figure 1A).